Navigation Links
Sirius Genomics Announces Change in Leadership
Date:12/9/2009

VANCOUVER, Dec. 8 /PRNewswire/ - Sirius Genomics, a developer of pharmacogenomic diagnostics, announced today that Chris Wagner has been appointed President and Chief Executive Officer, replacing Dr. Brad Popovich.

"We want to thank Brad for his strong leadership as President and CEO over the last four years. Brad has taken the Company from discovery to the commercialization phase in a very short period of time. Brad has also managed to recruit one of the best management teams I have seen in the companion diagnostic space," stated Dr. Heiner Dreismann, member of the Sirius Genomics Board of Directors.

Dr. Popovich will continue as member of Sirius Genomics Board and will continue to assist Mr. Wagner and the Company with the provision of strategic advice and support.

"The Sirius Board of Directors believes that this is the right time to make this transition in the evolution of the Company because we have initiated our validation studies on our Xigris Diagnostic and we are spending more time on commercialization and partnership initiatives. Mr. Wagner's extensive background in global pharmaceutical and diagnostic commercialization and partnering are the skills needed to move the Xigris Diagnostic forward from here. The Sirius Board appreciates the efforts of both Chris and Brad in making this transition so smooth and seamless," stated Dr. Jim McEwen, Chairman of the Board.

Chris Wagner has over 17 years of experience in marketing, sales and business development. Since 2007, Mr. Wagner was Vice President of Business Development at Sirius Genomics. Previously, Mr. Wagner was with Aspreva Pharmaceuticals as the Vice President of Marketing and Vice President of Business Development. Prior to Aspreva, Mr. Wagner was with Eli Lilly as an international service employee working in Europe, North America and Asia with positions based in Toronto, Indianapolis and Boston. Mr. Wagner holds a BSc in Organic Chemistry from the University of British Columbia.

About Sirius Genomics: www.siriusgenomics.com

Sirius Genomics is a drug-enabling company that develops pharmacogenomic (PGx) diagnostics that lead to better patient outcomes through personalized medicine. Sirius generates value by improving the safety and effectiveness of pharmaceutical compounds. The Company correlates patient genetics with clinical outcomes, leading to proprietary and commercially viable PGx products that enable better drug treatment. The Company's first product is a genetic predictor of response to treatment for sepsis, a severe blood infection.

This release contains forward-looking statements that are not based on historical fact. These forward-looking statements involve risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from those expressed or implied by such forward-looking statements. Readers are cautioned not to place undue reliance on such forward-looking statements.

SOURCE Sirius Genomics Inc.


'/>"/>
SOURCE Sirius Genomics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Learn Proven Practices to Measure, Align and Transform at SiriusDecisions Sales and Marketing Summit 2010
2. Dr. Robert Lanza is Featured Guest on Deepak Chopras SIRIUS XM Stars Radio Show
3. Sirius Genomics Announces 2009 Board of Directors
4. Sirius Genomics to Present at Invest Northwest Conference
5. Sirius Genomics Announces New Collaboration with UK Critical Care Genomics Group
6. NeoGenomics To Present at the Lazard Capital Markets 6th Annual Healthcare Conference on November 18, 2009
7. Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes
8. Clinical Genomics Continues Collaborative Research With CSIRO
9. NeoGenomics to Present at the Rodman & Renshaw Healthcare Investment Conference on September 10, 2009
10. AutoGenomics Invited to Present at Thomas Weisel Partners 2009 Healthcare Conference
11. International Milk Genomics & Human Health Symposium Speaker Program Announced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... Supplyframe, ... of the Supplyframe Design Lab . Located in Pasadena, Calif., the Design ... of how hardware projects are designed, built and brought to market. , The ...
(Date:6/23/2016)... LOUISVILLE, Ky. , June 23, 2016 /PRNewswire/ ... from two Phase 1 clinical trials of its ... double-blind, placebo-controlled, single and multiple ascending dose studies ... and pharmacodynamics (PD) of subcutaneous injection in healthy ... APL-2 subcutaneously (SC) either as a single dose ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology:
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
(Date:4/15/2016)... 2016  A new partnership announced today will ... decisions in a fraction of the time it ... high-value life insurance policies to consumers without requiring ... Force Diagnostics, rapid testing (A1C, Cotinine and HIV) ... pressure, weight, pulse, BMI, and activity data) available ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):